Back to top
more

Align Technology (ALGN)

(Delayed Data from NSDQ)

$136.52 USD

136.52
7,975,199

+7.51 (5.82%)

Updated Aug 1, 2025 04:00 PM ET

After-Market: $137.20 +0.68 (0.50%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 19% (46 out of 246)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Align Technology, based in California, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position.

Zacks Equity Research

Bruker Buys SCiLS, Expands in Mass Spectrometry Imaging

by Zacks Equity Research

Bruker Corporation (BRKR) recently announced the acquisition of Bremen, Germany-based software solutions developer, SCiLS GmbH.

    Zacks Equity Research

    ResMed Achieves Key Milestone in Sleep-Disordered Breathing

    by Zacks Equity Research

    After one billion nights of sleep data was downloaded using ResMed's remote patient monitoring platform AirView, the company reached a landmark in the field of sleep research and treatment of sleep apnea.

      Zacks Equity Research

      Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay

      by Zacks Equity Research

      Hologic, Inc. (HOLX) recently announced the receipt of the FDAs Premarket Approval (PMA) for its Aptima HIV-1 Quant assay.

        Zacks Equity Research

        IDEXX Laboratories (IDXX) Set to Join the S&P 500 Index

        by Zacks Equity Research

        IDEXX Laboratories, Inc. (IDXX) is scheduled to join the coveted S&P 500 benchmark, after the market closes on Jan 4.

          Zacks Equity Research

          Illumina Fettered With Losses: Can It Bounce Back in 2017?

          by Zacks Equity Research

          During majority of the past one year, Illumina (ILMN) lagged the Zacks classified broader Medical - Biomedical and Genetics industry.

            Zacks Equity Research

            Masimo to Launch Advanced Monitoring Technologies in India

            by Zacks Equity Research

            Masimo (MASI) announced that it will launch Advanced Monitoring Technologies in the Indian market.

              Zacks Equity Research

              OPKO Health (OPK) Reports Failure in hGH-CTP Phase 3

              by Zacks Equity Research

              OPKO Health Inc. (OPK) announced failure in its data analysis of the Phase 3 Clinical Study of hGH-CTP in Growth Hormone Deficient Adults.

                Zacks Equity Research

                Abaxis (ABAX) Veterinary Prospects Bright: Should You Hold?

                by Zacks Equity Research

                On Jan 2, 2017, Abaxis Inc. (ABAX), a leading manufacturer of portable medical and veterinary blood analysis systems, was upgraded to a Zacks Rank #3 (Hold).

                  Zacks Equity Research

                  Is Baxter Poised to Counter Low Cyclophosphamide Sales?

                  by Zacks Equity Research

                  On Dec 30, we issued an updated research report on Deerfield, IL-based Baxter International Inc. (BAX), a global medical technology company and leading provider of renal and hospital products.

                    Zacks Equity Research

                    CryoLife (CRY) Now a Strong Buy on Solid Estimate Revisions

                    by Zacks Equity Research

                    On Dec 27, CryoLife Inc. (CRY) was upgraded to a Zacks Rank #1 (Strong Buy).

                      Zacks Equity Research

                      Alere (ALR) Appeals to Reinstate Medicare Billing Privilege

                      by Zacks Equity Research

                      Alere Inc. (ALR) announced that it has recently appealed at the Centers for Medicare & Medicaid Services for reinstatement of Medicare billing privilege.

                        Zacks Equity Research

                        NuVasive (NUVA) Wins MHLW Approval for XLIF Device Suite

                        by Zacks Equity Research

                        NuVasive (NUVA) recently announced the receipt of approval from MHLW, for instruments used in the eXtreme Lateral Interbody Fusion (XLIF) procedure.

                          Zacks Equity Research

                          LabCorp: Covance Drug Prospects Bright, Competition Rife

                          by Zacks Equity Research

                          On Dec 28, we issued an updated research report on Burlington, NC-based Laboratory Corporation of America Holdings (LH).

                            Zacks Equity Research

                            ResMed: SDB Business Faces Risks, Reimbursement a Drag

                            by Zacks Equity Research

                            On Dec 27, we issued an updated research report on San Diego, CA-based ResMed, Inc. (RMD).

                              Zacks Equity Research

                              Nutrisystem Declares Multi-Brand Marketing Approach for '17

                              by Zacks Equity Research

                              Nutrisystem Inc. (NTRI) announced that it will focus on a multi-brand marketing approach with two new distinct programs.

                                Zacks Equity Research

                                What's in Store for Walgreens Boots (WBA) in Q1 Earnings?

                                by Zacks Equity Research

                                Walgreens Boots Alliance, Inc (WBA) is slated to release first-quarter 2017 results, before the market opens on Jan 5.

                                  Zacks Equity Research

                                  Cardiovascular Systems (CSII): Q1 Solid, Net Losses Linger

                                  by Zacks Equity Research

                                  On Dec 27, we issued an updated research report on St. Paul, MN-based Cardiovascular Systems, Inc. (CSII).

                                    Zacks Equity Research

                                    Align Technology Hits 52-Week High on Q3 & Dental Strength

                                    by Zacks Equity Research

                                    Share price of San Jose, CA-based Align Technology, Inc. (ALGN) scaled a new 52-week high of $102.1 on Dec 19, finally closing a bit lower at $100.3.

                                      Zacks Equity Research

                                      Align Up on Balanced Growth, Expansion of Invisalign Teen

                                      by Zacks Equity Research

                                      On Dec 9, 2016, we issued an updated research report on California-based Align Technology Inc. (ALGN).

                                        Zacks Equity Research

                                        Zacks.com featured highlights: Movado Group, Align Technology, Arch Capital Group, Gibraltar Industries and Rogers

                                        by Zacks Equity Research

                                        Zacks.com featured highlights: Movado Group, Align Technology, Arch Capital Group, Gibraltar Industries and Rogers

                                          Zacks Equity Research

                                          Think Like Driehaus and Invest in These Stocks

                                          by Zacks Equity Research

                                          "Buy high and sell higher" is the basic principle of most momentum strategies.

                                            Zacks Equity Research

                                            Top Ranked Momentum Stocks to Buy for December 1st

                                            by Zacks Equity Research

                                            Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, December 1st:

                                              Tirthankar Chakraborty headshot

                                              New Strong Buy Stocks for December 1st

                                              by Tirthankar Chakraborty

                                              Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday

                                                Eric Dutram headshot

                                                Bull of the Day: Align Technology (ALGN)

                                                by Eric Dutram

                                                Things are lining up nicely for a beat in this stock when it reports earnings later this month thanks to rising estimates.